Highly sensitive detection of hepatitis B virus surface antigen by use of a semiautomated immune complex transfer chemiluminescence enzyme immunoassay

Journal of Clinical Microbiology

Volumn 51, Issue 7, 2013, Pages 2238-2244

  Takeda, Kazuhiko ^a   Maruki, Mari ^a   Yamagaito, Takahiro ^a   Muramatsu, Machiko ^a   Sakai, Yasuhiro ^a   Tobimatsu, Hiroaki ^a   Kobayashi, Hironori ^a   Mizuno, Yoshiteru ^a   Hamaguchi, Yukio ^a  

^a SYSMEX CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; NEUTRALIZING ANTIBODY; ANTIGEN ANTIBODY COMPLEX;

ACCURACY; ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN DETECTION; ARTICLE; CALIBRATION; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE COMPLEX TRANSFER; IMMUNOLOGICAL PROCEDURES; INTERMETHOD COMPARISON; LIMIT OF DETECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; VIRUS DETECTION; VIRUS LOAD; VIRUS REACTIVATION; BLOOD; COMPARATIVE STUDY; DIAGNOSTIC PROCEDURE; ENZYME IMMUNOASSAY; EVALUATION STUDY; HUMAN; IMMUNOLOGY; LUMINESCENCE; PROCEDURES;

HEPATITIS B VIRUS;

ANTIGEN-ANTIBODY COMPLEX; CLINICAL LABORATORY TECHNIQUES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; LUMINESCENCE; SENSITIVITY AND SPECIFICITY;

EID: 84879456711     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00324-13     Document Type: Article

References (43)

1. World Health Organization. 2012. Hepatitis B. WHO, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs204/en/.
2. Ganem D, Prince AM. 2004. Hepatitis B virus infection-natural history and clinical consequences. N. Engl. J. Med. 350:1118-1129.
3. Allain J-P, Candotti D, Soldan K, Phelps B, Giachetti C, Shyamala V, Yeboah F, Ankowa M, Owusu-Ofori S, Opare-Sem O. 2003. The risk of hepatitis B virus infection by transfusion in Kumai, Ghana. Blood 101: 2419-2425.
4. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddada L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP. 2003. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 43:788-798.
5. Linauts S, Saldanha J, Strong DM. 2008. PRISM hepatitis B surface antigen detection of hepatitis B virus minipool nucleic acid testing yield samples. Transfusion 48:1376-1382.
6. Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Roux ML, Kuun E, Gulube S, Reddy R. 2009. Impact of individualdonation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion 49:1115-1125.
7. Norder H, Couroucé Coursaget A-MP, Echevarria JM, Lee Mushahwar S-DIK, Robertson BH, Locarnini S, Magnius LO. 2004. Genetic diversity of hepatitis B virus strains derived worldwide; genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289-309.
8. Olinger CH, Jutavijittum P, Hübschen JM, Yousukh A, Samountry B, Thammavong T, Toriyama K, Muller CP. 2008. Possible new hepatitis B virus genotype, southeast Asia. Emerg. Infect. Dis. 14:1777-1780.
9. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, Nakayoshi T, Wakuta M, Miyakawa Y, Mizokami M. 2009. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J. Virol. 83:10538-10547.
10. Coleman PF, Chen YCJ, Mushahwar IK. 1999. Immunoassay detection of hepatitis B surface antigen mutants. J. Med. Virol. 59:19-24.
11. Ge J-H, Liu H-M, Sun J, Zhang L-Z, He J, Li Y-L, Liu H, Xu Y, Yu H-Y, Hu Y-P. 2004. Antigenic and immunogenic changes due to mutation of s gene of HBV. World J. Gastroenterol. 10:3137-3140.
12. Ly TD, Servant-Delmas A, Bagot S, Gonzalo S, Férey Ebel M-PA, Dussaix E, Laperche S, Roque-Afonso A-M. 2006. Sensitivity of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms. J. Clin. Microbiol. 44:2321-2326.
13. Moerman B, Moons V, Sommer H, Schmitt Y, Stetter M. 2004. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin. Lab. 50:159-162.
14. Scheiblauer H, Soboll H, Nick S. 2006. Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection. J. Med. Virol. 78:S66-S70.
15. Seddigh-Tonekaboni S, Waters JA, Jeffers S, Geheke R, Ofenloch B, Horsch A, Hess G, Thomas HC, Karayiannis P. 2000. Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J. Med. Virol. 60:113-121.
16. Tian Y, Xu Y, Zhang Z, Meng Z, Qin L, Lu M, Yang D. 2007. The amino acid residues at position 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J. Clin. Microbiol. 45:2971-2978.
17. Gerlich WH. 2004. Diagnostic problems caused by HBsAg mutants-a consensus report of an expert meeting. Intervirology 47:310-313.
18. Hashida S, Hashinaka K, Nishikata I, Oka S, Shmada K, Saitoh A, Takamizawa A, Shinagawa H, Ishkawa E. 1995. Measurement of human immunodeficiency virus type 1 p24 in serum by an ultrasensitive enzyme immunoassay, the two-site immune complex transfer enzyme immunoassay. J. Clin. Microbiol. 33:298-303.
19. Hashida S, Ishikawa S, Hashinaka K, Nishikata I, Oka S, Ishikawa E. 2000. Earlier detection of human immunodeficiency virus type 1 p24 antigen and immunoglobulinG and Mantibodies to p17 antigen in seroconversion serum panels by immune complex transfer enzyme immunoassay. Clin. Diagn. Lab. Immunol. 7:872-881.
20. Meng Q, Wong C, Rangachari A, Tamatsukuri S, Sasaki M, Fiss E, Cheng L, Ramankutty T, Clarke D, Yawata H, Sasakura Y, Hirose T, Impraim C. 2001. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA. J. Clin. Microbiol. 39:2937-2945.
21. Minegishi K, Yoshikawa A, Kishimoto S, Yugi H, Yokoya N, Sakurada M, Kiyokawa H, Nishioka K, the Japanese Red Cross Screening Research Group NAT. 2003. Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening. Vox Sang. 84:287-291.
22. Wiedmann M, Kluwick S, Walter M, Fauchald G, Howe J, Bronold M, Zauke M. 2007. HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconversion donors. J. Clin. Microbiol. 39:282-287.
23. Alter MJ. 2006. Epidemiology of viral hepatitis and HIV co-infection. J. Hepatol. 44(1 Suppl):S6-S9.
24. Thio CL. 2009. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 49:S138-S145.
25. Brodersen H-P, Beckers B, Köhler H, Dahlmanns C, Kruska L, Larbig D. 1997. The test for hepatitis B surface antigen is transiently positive after vaccination with recombinant vaccine. Nephrol. Diagn. Transplant. 12: 2756-2757.
26. Dow BC, Yates P, Galea G, Munro H, Buchanan I, Ferguson K. 2002. Hepatitis B vaccines may be mistaken for confirmed hepatitis B surface antigen-positive blood donors. Vox Sang. 82:15-17.
27. Janzen L, Minuk GY, Fast M, Bernstein KN. 1996. Vaccine-induced hepatitis B surface antigen positivity in adult hemodialysis patients: incidental and surveillance data. J. Am. Soc. Nephrol. 7:1228-1234.
28. Kloster B, Kramer R, Eastlund T, Grossman B, Zarvan B. 1995. Hepatitis B surface antigenemia in blood donors following vaccination. Transfusion 35:475-477.
29. Köksal N, Altinkaya N, Perk Y. 1996. Transient hepatitis B surface antigenemia after neonatal hepatitis B immunization. Acta Pediatr. 85: 1501-1502.
30. Lunn ER, Hoggarth BJ, Cook WJ. 2000. Prolonged hepatitis B surface antigenemia after vaccination. Pediatrics 105:e81.
31. Mantadakis E, Thomaidis S, Efraimidou Ramatani E-NA, Chatzimichael A. 2010. Transient hepatitis B surface antigen circulation after Infanrix-Hexa: a case report and review of the literature. Eur. J. Pediatr. 169:1139-1141.
32. Otaǧ F. 2003. False positive HBsAg result in blood donors due to admin-istration of three different recombinant DNA hepatitis B vaccines. Vaccine 21:3734-3737.
33. Kimura T, Rokuhara A, Sakamoto Y, Yagi S, Tanaka E, Kiyosawa K, Maki N. 2002. Sensitive immunoassay for hepatitis B virus core-related antigens and their correlation to virus load. J. Clin. Microbiol. 40:439-445.
34. Blanpain C, Knoop C, Delforge ML, Antoine M, Peny MO, Liesnard C, Vereerstraeten P, Cogan E, Adler M, Abramowicz D. 1998. Reactivation of hepatitis B after transplantation in patients with preexisting antihepatitis B surface antigen antibodies: report on three cases and review of the literature. Transplantation 66:883-886.
35. Kempinska A, Kwak EJ, Angel JB. 2005. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature. Clin. Infect. Dis. 41:1277-1282.
36. Ide Y, Ito Y, Takahashi S, Tokudome N, Kobayashi K, Sugihara T, Hattori M, Yokoyama M, Uchiyama A, Inoue K, Sakurai N, Hatake K. 24 July 2010. Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer. Breast Cancer [Epub ahead of print.] doi:10.1007/s12282-010-0213-x.
37. Dervite I, Hober D, Morel P. 2001. Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N. Engl. J. Med. 344:68-69.
38. Kim EB, Kim DS, Park SJ, Park Y, Rho KH, Kim SJ. 2008. Hepatitis B virus reactivation in a surface antigen-negative and antibody-positive patient after rituximab plus CHOP chemotherapy. Cancer Res. Treat. 40: 36-38.
39. Ozaras R, Ar C, Ongoren S, Mete B, Tabak F, Mert A, Ozturk R. 2010. Acute hepatitis B despite a previous high titer of anti-HBs. Hepatol. Int. 4:530-532.
40. Urata Y, Uesato R, Tanaka D, Kowatari K, Nitobe T, Nakamura Y, Motomura S. 2011. Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients. Mod. Rheumatol. 21:16-23.
41. Manegold C, Hannoun C, Wywiol A, Dietrich M, Polywka S, Chiwakata CB, Günther S. 2001. Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiviral therapy. 32:144-148.
42. Pei S-N, Ma M-C, Wang M-C, Kuo C-Y, Rau K-M, Su C-Y, Chen C-H. 2012. Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy. Ann. Hematol. 91:1007-1012.
43. Yoshida T, Kusumoto S, Inagaki A, Mori F, Ito A, Ri M, Ishida T, Komatsu H, Iida S, Sugauchi F, Tanaka Y, Mizokami M, Ueda R. 2010. Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reports. Int. J. Hematol. 91:844-849.